You must be logged in to access this content
Originally aired on Wednesday 27 March 2024, 15:30 – 17:00 (GMT)
This webinar, chaired by Dr Christopher Stewart (AMI’s 2023 WH Pierce Prize awardee), will bring together leading researchers to unravel the complexities of the human microbiome's role in early development. Our panellists will explore a range of critical topics, from the intricacies of microbiota-host interactions to the latest advancements in microbiome research methodologies. They will debate the challenges faced in translating research into effective therapies and public health policies, and discuss the future directions and potential breakthroughs in the field. The conversation will aim to shed light on the profound impact of the microbiome on early life health.
Initially, the event will showcase individual research highlighting diverse methods and findings pertinent to early life health and disease. Following these short presentations, an expert panel discussion will provide a platform for debate and analysis of current microbiome research.
Don't forget to complete our feedback survey after the webinar to recieve your certificate of attendance and CPD points.
| Speaker/Panellist | Title |
|---|---|
| Dr Christopher Stewart (Newcastle University, UK) | Multi-omic analysis of clinical samples |
| Professor Meghan Azad (University of Manitoba, Canada) | Breastfeeding and breast milk: biological mechanisms and public health implications |
| Professor Lindsay Hall (University of Birmingham, UK) | Early life microbiota and understanding the interplay between beneficial and pathogenic microbes |
| Dr Trevor Lawley (Wellcome Sanger Institute, UK) | Gut microbial communities and their comprehensive impact on human physiology and disease |
| Dr Sasirekha Ramani (Baylor College of Medicine, USA) | Human intestinal organoids as models for gastrointestinal microbial interactions |
Dr Christopher Stewart
Professor Meghan Azad
Professor Lindsay Hall
Dr Trevor Lawley
Dr Sasirekha Ramani
This event underscores Applied Microbiology International's commitment to enhancing neonatal health care and nutrition strategies, contributing to the broader UN SDGs ensuring healthy lives and promoting well-being for all ages.
SDG 3: Good Health and Well-being
Target 3.2 - End Preventable Deaths of Newborns and Children Under 5 Years of Age: Dr Stewart's work on the microbiome in preterm infants, especially his research on human milk oligosaccharides (HMO) and their impact on the gut microbiome, contributes to a better understanding of neonatal health. This research can help in developing strategies to reduce infant mortality and enhance early childhood health.
Target 3.8 - Achieve Universal Health Coverage: His findings can inform healthcare practices and policies, especially in neonatal care, contributing to the goal of universal health coverage with improved outcomes for infants.
SDG 4: Quality Education
Target 4.2 - Ensure Quality Early Childhood Development: Understanding the role of the gut microbiome in early development is crucial for informing educational and health policies that support early childhood development.
SDG 2: Zero Hunger
Target 2.2 - End All Forms of Malnutrition: Insights from his research on the gut microbiome and nutrition in early life could lead to better strategies for nutrition, particularly in the context of breastfeeding and novel therapies, thereby contributing to efforts to combat malnutrition.
